Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; ''ecstasy'')

被引：28

作者：

Cohen, RS

机构：

[1] Research Department, Peapack, NJ

[2] Research Department, Peapack, NJ 07977

来源：

BIOLOGICAL PSYCHIATRY | 1996年 / 39卷 / 09期

关键词：

ecstasy; MDMA; drug use; serotonin; suicide;

D O I：

10.1016/0006-3223(95)00551-X

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

[No abstract available]

引用

下载

页码：819 / 820

页数：2

共 50 条

[1] Methylenedioxymethamphetamine (MDMA, "Ecstasy")
Shannon, M
PEDIATRIC EMERGENCY CARE, 2000, 16 (05) : 377 - 380
[2] Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy')
McCann, UD
Slate, SO
Ricaurte, GA
DRUG SAFETY, 1996, 15 (02) : 107 - 115
[3] 3,4-methylenedioxymethamphetamine (MDMA, or ''ecstasy'') and associated hypoglycemia
Montgomery, H
Myerson, S
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 1997, 15 (02): : 218 - 218
[4] Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use
Bedi, G.
Van Dam, N. T.
Redman, J.
JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (02) : 233 - 240
[5] Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): Neurodegeneration versus Neuromodulation
Puerta, Elena
Aguirre, Norberto
PHARMACEUTICALS, 2011, 4 (07): : 992 - 1018
[6] Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA)
Morimoto, BH
Lovell, S
Kahr, B
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1998, 54 : 229 - 231
[7] Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system
Connor, TJ
IMMUNOLOGY, 2004, 111 (04) : 357 - 367
[8] ECSTASY, 3-4 METHYLENEDIOXYMETHAMPHETAMINE (MDMA), A FATALITY ASSOCIATED WITH COAGULOPATHY AND HYPERTHERMIA
CHADWICK, IS
CURRY, PD
LINSLEY, A
FREEMONT, AJ
DORAN, B
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1991, 84 (06) : 371 - 371
[9] Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?
Allott, Kelly
Redman, Jennifer
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2007, 31 (03): : 327 - 347
[10] Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA; ''Ecstasy'')
Cohen, RS
Cocores, J
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1997, 21 (04): : 727 - 734

← 1 2 3 4 5 →